These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22998347)

  • 1. The evaluation of apomorphine for the treatment of erectile dysfunction.
    Mohee A; Bretsztajn L; Eardley I
    Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1447-53. PubMed ID: 22998347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative review of apomorphine formulations for erectile dysfunction : recommendations for use in the elderly.
    Briganti A; Chun FK; Salonia A; Zanni G; Dehò F; Barbieri L; Karakiewicz PI; Rigatti P; Montorsi F
    Drugs Aging; 2006; 23(4):309-19. PubMed ID: 16732690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging oral drugs for erectile dysfunction.
    Briganti A; Salonia A; Gallina A; Suardi N; Rigatti P; Montorsi F
    Expert Opin Emerg Drugs; 2004 May; 9(1):179-89. PubMed ID: 15155143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterising the benefit of apomorphine SL (Uprima) as an optimised treatment for representative populations with erectile dysfunction.
    Heaton JP
    Int J Impot Res; 2001 Aug; 13 Suppl 3():S35-9. PubMed ID: 11477490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual apomorphine: new preparation. In erectile disorders: a narrow therapeutic margin.
    Prescrire Int; 2002 Jun; 11(59):76-9. PubMed ID: 12068841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction.
    Mulhall JP; Bukofzer S; Edmonds AL; George M;
    Clin Ther; 2001 Aug; 23(8):1260-71. PubMed ID: 11558862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
    Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
    Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and safety of apomorphine SL (Ixense (TM) ).
    Montorsi F
    Int J Impot Res; 2003 Apr; 15 Suppl 2():S7-9. PubMed ID: 12825097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine for the Treatment of Erectile Dysfunction: Systematic Review and Meta-Analysis.
    Guillén V; Rueda JR; Lopez-Argumedo M; Solà I; Ballesteros J
    Arch Sex Behav; 2020 Nov; 49(8):2963-2979. PubMed ID: 32964351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral treatment of erectile dysfunction with apomorphine SL.
    Altwein JE; Keuler FU
    Urol Int; 2001; 67(4):257-63. PubMed ID: 11741126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual apomorphine for the treatment of erectile dysfunction.
    Mulhall JP
    Expert Opin Investig Drugs; 2002 Feb; 11(2):295-302. PubMed ID: 11829718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
    Afif-Abdo J; Teloken C; Damião R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
    BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential administration enhances the effect of apomorphine SL in men with erectile dysfunction.
    Heaton JP; Dean J; Sleep DJ
    Int J Impot Res; 2002 Feb; 14(1):61-4. PubMed ID: 11896482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction.
    Axilrod AC
    Curr Med Res Opin; 2007 Dec; 23(12):3189-98. PubMed ID: 17991309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men.
    Gontero P; D'Antonio R; Pretti G; Fontana F; Panella M; Kocjancic E; Allochis G; Frea B
    Int J Impot Res; 2005; 17(1):80-5. PubMed ID: 15510184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of apomorphine SL (Uprima).
    Bukofzer S; Livesey N
    Int J Impot Res; 2001 Aug; 13 Suppl 3():S40-4. PubMed ID: 11477491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of erectile function by the oral administration of apomorphine.
    Heaton JP; Morales A; Adams MA; Johnston B; el-Rashidy R
    Urology; 1995 Feb; 45(2):200-6. PubMed ID: 7855966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
    Eardley I; Wright P; MacDonagh R; Hole J; Edwards A
    BJU Int; 2004 Jun; 93(9):1271-5. PubMed ID: 15180621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on oral treatments for male erectile dysfunction.
    Kalsi JS; Kell PD
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury.
    Strebel RT; Reitz A; Tenti G; Curt A; Hauri D; Schurch B
    BJU Int; 2004 Jan; 93(1):100-4. PubMed ID: 14678378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.